The reality is, and in spite of thoughts to the contrary, covid is not going anywhere soon. Thus rapid antigen testing is still far removed from being a bookmark in history. In fact, based on the following articles the need and demand is growing exponentially.
Take the following article for example and the Ontario governments decision to send rapid antigen tests home with every student in the province.
https://www.cp24.com/news/ontario-to-send-rapid-antigen-tests-home-with-all-2-2-million-school-children-for-winter-break-1.5671743 Then there are the manufacturing issues that can lead to a recall.
https://www.self.com/story/ellume-rapid-test-recall The following represents a window into the concerns around American Thanksgiving. Note the high number of cases in children and the unvaccinated. As long as vaccination rates are below a certain threshold covid infections among the vaccinated and unvaccinated will continue to rise.
https://www.democratandchronicle.com/story/news/2021/11/19/monroe-county-additional-free-rapid-antigen-testing-thanksgiving-test-sites/8667889002/ ....and then there's Europe, a harbinger of the reality even within countries where vaccination rates are relatively high or the dismal reality of a national lockdown if they are low.
https://www.ctvnews.ca/health/coronavirus/facing-surge-austria-will-mandate-covid-19-shots-lock-down-1.5672903 Can AcuVid be a big player amongst the giants of Pharma ....absolutely. THRMs' AcuVid has cleared all the hurdles the FDA has thrown out there and there's no reason to believe this last expectation won't be met. Imho it would seem the FDA EUA is just around the corner. Anyone who has come this far would be wise to stick it out just a while longer ....and put mechanisms in place to protect their investment ...as all investors should do.
It should be a wild ride to the end of 2021.
GLTE ....holding patiently!!!